Literature DB >> 29951736

Molecular Cloning and Biochemical Characterization of Iron Superoxide Dismutase from Leishmania braziliensis.

Camila C B Brito1, Fernando V Maluf2, Gustavo M A de Lima2,3, Rafael V C Guido2, Marcelo S Castilho4,5.   

Abstract

Leishmaniasis is one of the most important neglected tropical diseases, with a broad spectrum of clinical manifestations. Among the clinical manifestations of the disease, cutaneous leishmaniasis, caused by species of Leishmania braziliensis, presents wide distribution in Brazil. In this work, we performed the cloning, expression, and purification of the enzyme superoxide dismutase of Leishmania braziliensis (LbSOD-B2) considered a promising target for the search of new compounds against leishmaniasis. In vitro assays based on pyrogallol oxidation showed that LbSOD-B2 is most active around pH 8 and hydrogen peroxide is a LbSOD-B2 inhibitor at low millimolar range (IC50 = 1 mM).

Entities:  

Keywords:  Heterologous expression; Kinetic assay; Leishmania braziliensis; Superoxide dismutase

Mesh:

Substances:

Year:  2018        PMID: 29951736     DOI: 10.1007/s12033-018-0095-2

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  32 in total

1.  Ligation-independent cloning of PCR products (LIC-PCR).

Authors:  C Aslanidis; P J de Jong
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

2.  Pyrogallol red oxidation induced by superoxide radicals: application to evaluate redox cycling of nitro compounds.

Authors:  M Faúndez; M Rojas; P Bohle; C Reyes; M E Letelier; M E Aliaga; H Speisky; E Lissi; C López-Alarcón
Journal:  Anal Biochem       Date:  2011-09-01       Impact factor: 3.365

3.  Biochemical and electron paramagnetic resonance study of the iron superoxide dismutase from Plasmodium falciparum.

Authors:  Sylvie Gratepanche; Stéphane Ménage; Danièle Touati; René Wintjens; Patrick Delplace; Marc Fontecave; Annick Masset; Daniel Camus; Daniel Dive
Journal:  Mol Biochem Parasitol       Date:  2002-04-09       Impact factor: 1.759

4.  Evaluating 5-Nitrothiazoles as Trypanocidal Agents.

Authors:  Ivan P O'Shea; Mohammed Shahed; Benjamín Aguilera-Venegas; Shane R Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

5.  The pyrogallol assay for superoxide dismutase: absence of a glutathione artifact.

Authors:  E F Roth; H S Gilbert
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

Review 6.  The effects of nitric oxide on the immune system during Trypanosoma cruzi infection.

Authors:  Fredy R S Gutierrez; Tiago W P Mineo; Wander R Pavanelli; Paulo M M Guedes; João S Silva
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

7.  Use of antimony in the treatment of leishmaniasis: current status and future directions.

Authors:  Arun Kumar Haldar; Pradip Sen; Syamal Roy
Journal:  Mol Biol Int       Date:  2011-06-08

8.  Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden.

Authors:  Manu Vanaerschot; Simonne De Doncker; Suman Rijal; Louis Maes; Jean-Claude Dujardin; Saskia Decuypere
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

9.  Molecular diagnosis of cutaneous leishmaniasis and identification of the causative Leishmania species in Morocco by using three PCR-based assays.

Authors:  Tarik Mouttaki; Manuel Morales-Yuste; Gema Merino-Espinosa; Soumiya Chiheb; Hassan Fellah; Joaquina Martin-Sanchez; Myriam Riyad
Journal:  Parasit Vectors       Date:  2014-09-04       Impact factor: 3.876

10.  Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.

Authors:  Maria Del Mar Castro; Alexandra Cossio; Carlos Velasco; Lyda Osorio
Journal:  PLoS Negl Trop Dis       Date:  2017-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.